Talkiatry Pushes Therapy Nationwide, Betting on Integrated Care to Close Behavioral Health Gaps

Talkiatry has moved beyond psychiatry alone. The national mental health practice now offers virtual therapy in all 50 states, directly employing more than 400 therapists, 85% of whom hold licenses in multiple states. The expansion builds on a telepsychiatry business that already counts more than 800 employed psychiatrists, making Talkiatry the largest private employer of psychiatrists in the country.

The thesis is straightforward: fragmented care fails patients. Psychiatrists and therapists typically operate in separate networks with little communication between them, and patients bounce between providers who have never spoken to each other. Talkiatry's co-founder and chief medical officer, Georgia Gaveras, DO, argues that bringing both disciplines into one ecosystem removes that friction. "If you have providers in the same ecosystem, the Talkiatry ecosystem, that can provide therapy and medication management, then all of a sudden it makes it a lot easier to coordinate care," she said.

The scale here is notable. Talkiatry now spans more than 100 insurers, covers over 170 million lives, and has delivered more than 4 million patient visits since its 2020 founding by Gaveras and Robert Krayn. The company has raised $400 million to date, including a $210 million Series D closed in February, and is a preferred in-network psychiatry partner for more than 70 U.S. health systems. In April, it partnered with AMGA to extend in-network psychiatric access to medical groups.

Why it matters

The market backdrop explains the urgency. Roughly 60 million American adults live with a mental illness, yet only about half receive treatment in a given year, according to National Institute of Mental Health data. The average wait for behavioral health services runs 48 days. Nearly 137 million Americans, 40% of the population, live in federally designated Mental Health Professional Shortage Areas, and the Health Resources and Services Administration projects the psychiatrist supply will shrink roughly 20% by 2030.

Untreated mental illness is not just a clinical problem. A 2024 National Bureau of Economic Research study pegged the annual cost of untreated or undertreated mental illness at roughly $282 billion in lost work and reduced economic participation. Emergency departments absorb billions more in avoidable visits tied to patients who never got coordinated care. That is the economic case Talkiatry is leaning on to court health systems, payers and employers who need capacity without building it themselves.

Gaveras frames the company's role as complementary rather than competitive to existing health systems. "We're not replacing anything; we're complementing them," she said, adding that systems want a trusted referral partner when they cannot meet demand internally. That positioning matters for a company trying to scale across 70-plus health system relationships without threatening the institutions it partners with.

Telehealth's own growing pains add another layer. Gaveras noted that multi-state licensure has become "a moving target" since the pandemic, creating inconsistent care for patients who move, travel or live near state lines. Legislation introduced this year, the Mental Health TALK SAFE Act of 2025, aims to establish permanent telehealth prescribing and licensing rules. Jesse Ehrenfeld, M.D., past president of the American Medical Association, urged Congress in a September commentary in the American Journal of Managed Care to advance the bill, arguing it would meaningfully expand telepsychiatry access.

Outcomes data is where Talkiatry is making its clinical case. Patients who see both a Talkiatry therapist and psychiatrist stay connected to care twice as long as those receiving psychiatric care alone, according to company executives. Nearly 85% of Talkiatry therapists build a positive therapeutic relationship with patients within the first month, based on internal clinical quality measurement. A published study of Talkiatry patients found average symptom reductions of 46% for anxiety and 45% for depression among those starting with moderate-to-severe symptoms, over roughly three months of treatment. A separate peer-reviewed study found the company's early dropout rate running up to 60% below industry benchmarks.

David Guggenheim, Talkiatry's national director of psychotherapy, framed the expansion as closing a structural gap rather than adding a feature. "Patients often come to us after bouncing between a therapist and a psychiatrist who've never spoken. That disconnect is where care falls through the cracks," he said.

The company is not stopping at individual therapy. It has expanded into group therapy, plans to pilot an Intensive Outpatient Program, and is exploring substance use treatment as a specialty area. Technology underpins the operation: proprietary AI tools manage care delivery and clinical operations, including AI scribes that handle note-taking, which Gaveras said is meant to improve the experience for both patients and doctors rather than replace clinical judgment.

Key risks

Scaling a therapist workforce nationally is a different operational challenge than scaling psychiatry, which leaned more heavily on remote prescribing and medication management. Therapy demands sustained engagement, consistent quality across hundreds of clinicians, and licensure management across state lines even as the regulatory landscape shifts. Talkiatry's claim that 85% of its therapists build rapport within a month is a strong internal metric, but it will need to hold up at scale as the therapist base grows well beyond its current headcount.

There is also a reimbursement question. Talkiatry's in-network model across 100-plus insurers is a genuine differentiator against out-of-network competitors, but insurer rate pressure and utilization management could squeeze margins as volume grows. The company's pitch to employers and payers rests partly on cost avoidance, fewer ED visits, less lost productivity, that is harder to quantify and monetize directly than per-visit revenue.

The Bottom Line

Talkiatry's nationwide therapy rollout is a logical extension of a model built on integration rather than volume alone. The company has real scale: 800-plus psychiatrists, 400-plus therapists, 170 million covered lives, and published outcomes data that compare favorably to industry benchmarks. Whether that translates into durable advantage depends on execution at scale and on how quickly policy, particularly multi-state licensure reform, catches up to the telehealth model Talkiatry has built its business around.